pneumocandin a(0) has been researched along with sulfamethoxazole in 1 studies
| Studies (pneumocandin a(0)) | Trials (pneumocandin a(0)) | Recent Studies (post-2010) (pneumocandin a(0)) | Studies (sulfamethoxazole) | Trials (sulfamethoxazole) | Recent Studies (post-2010) (sulfamethoxazole) |
|---|---|---|---|---|---|
| 19 | 0 | 3 | 5,813 | 680 | 1,216 |
| Protein | Taxonomy | pneumocandin a(0) (IC50) | sulfamethoxazole (IC50) |
|---|---|---|---|
| Dihydropteroate synthase | Escherichia coli K-12 | 4.7 | |
| 5-hydroxytryptamine receptor 2A | Rattus norvegicus (Norway rat) | 4.7 | |
| Dihydrofolate reductase | Pneumocystis carinii | 0.1 | |
| Endothelin-1 receptor | Rattus norvegicus (Norway rat) | 4 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (100.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fromtling, RA; Nollstadt, KH; Pittarelli, LA; Romancheck, MA; Schmatz, DM; Schwartz, RE; Turner, MJ; Vanmiddlesworth, FL; Wilson, KE | 1 |
1 other study(ies) available for pneumocandin a(0) and sulfamethoxazole
| Article | Year |
|---|---|
Treatment of Pneumocystis carinii pneumonia with 1,3-beta-glucan synthesis inhibitors.
Topics: Animals; Anti-Bacterial Agents; Antifungal Agents; Candida albicans; Disease Models, Animal; Echinocandins; Glucans; Lung; Male; Peptides; Peptides, Cyclic; Pneumocystis; Pneumonia, Pneumocystis; Pyrans; Rats; Rats, Inbred Strains; Sulfamethoxazole; Trimethoprim | 1990 |